TuHURA Biosciences
HURA
65 hedge funds and large institutions have $4.88M invested in TuHURA Biosciences in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 13 reducing their positions, and 12 closing their positions.
115% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 13
7% less funds holding
Funds holding: 70 → 65 (-5)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
68% less capital invested
Capital invested by funds: $15.2M → $4.88M (-$10.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$296K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$106K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$103K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$95.9K |
| 5 |
BlackRock
New York
|
+$85K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$217K |
| 2 |
BJL
Brighton Jones LLC
Seattle,
Washington
|
-$68.8K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$57.3K |
| 4 |
LPL Financial
San Diego,
California
|
-$56.8K |
| 5 |
SG Americas Securities
New York
|
-$41K |
HURA Hedge Fund Activity: Q4 2025 in Review
65 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q4 2025, worth a combined $4.88M — down 68% from $15.2M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of HURA and 7 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 28 added.
The largest buyer was Morgan Stanley, adding an estimated $296K. The largest seller was UBS Group, cutting an estimated $217K.
- 65 institutional investors held TuHURA Biosciences (HURA) as of Q4 2025, down from 70 in Q3 2025.
- Funds reported $4.88M of TuHURA Biosciences stock for Q4 2025, down 68% quarter-over-quarter.
- 7 funds opened new TuHURA Biosciences positions in Q4 2025 and 12 closed out, a net change of -5 holders.
- The largest TuHURA Biosciences buyer in Q4 2025 was Morgan Stanley, an estimated $296K added.
- The largest TuHURA Biosciences seller in Q4 2025 was UBS Group, an estimated $217K sold.
Based on aggregated 13F filings for Q4 2025.